(Stroke. 1999;30:1687-1694.)
© 1999 American Heart Association, Inc.
Original Contributions |
From Clinica Neurologica, Dipartimento di Neuroscienze, Università Tor Vergata (P.C., G.A.M., A.P., G.B.), and IRCCS Ospedale Santa Lucia (P.C., G.B.), Rome, and Dipartimento di Neuroscienze, Università Federico II (S.A.), Naples, Italy.
Correspondence to Paolo Calabresi, Clinica Neurologica, Dipartimento di Neuroscienze, Università "Tor Vergata," via di Tor Vergata 135, 00133, Rome, Italy. E-mail calabre{at}uniroma2.it
Background and PurposeNeuronal Na+/Ca2+ exchanger plays a relevant role in maintaining intracellular Ca2+ and Na+ levels under physiological and pathological conditions. However, the role of this exchanger in excitotoxicity and ischemia-induced neuronal injury is still controversial and has never been studied in the same neuronal subtypes.
MethodsWe investigated the effects of bepridil and 3',4'-dichlorobenzamil (DCB), 2 blockers of the Na+/Ca2+ exchanger, in rat striatal spiny neurons by utilizing intracellular recordings in brain slice preparations to compare the action of these drugs on the membrane potential changes induced either by oxygen and glucose deprivation (OGD) or by excitatory amino acids (EAAs).
ResultsBepridil (3 to 100 µmol/L) and DCB (3 to 100 µmol/L) caused a dose-dependent enhancement of the OGD-induced depolarization measured in striatal neurons. The EC50 values for these effects were 31 µmol/L and 29 µmol/L, respectively. At these concentrations neither bepridil nor DCB altered the resting membrane properties of the recorded cells (membrane potential, input resistance, and current-voltage relationship). The effects of bepridil and DCB on the OGD-induced membrane depolarization persisted in the presence of D-2-amino-5-phosphonovalerate (50 µmol/L) plus 6-cyano-7-nitroquinoxaline-2,3-dione (20 µmol/L), which suggests that they were not mediated by an enhanced release of EAAs. Neither tetrodotoxin (1 µmol/L) nor nifedipine (10 µmol/L) affect the actions of these 2 blockers of the Na+/Ca2+ exchanger, which indicates that voltage-dependent Na+ channels and L-type Ca2+ channels were not involved in the enhancement of the OGD-induced depolarization. Conversely, the OGD-induced membrane depolarization was not altered by 5-(N,N-hexamethylene) amiloride (1 to 3 µmol/L), an inhibitor of the Na+/H+ exchanger, which suggests that this antiporter did not play a prominent role in the OGD-induced membrane depolarization recorded from striatal neurons. Bepridil (3 to 100 µmol/L) and DCB (3 to 100 µmol/L) did not modify the amplitude of the excitatory postsynaptic potentials evoked by cortical stimulation. Moreover, these blockers did not affect membrane depolarizations caused by brief applications of glutamate (0.3 to 1 mmol/L), AMPA (0.3 to 1 µmol/L), and NMDA (10 to 30 µmol/L).
ConclusionsThese results provide pharmacological evidence that the activation of the Na+/Ca2+ exchanger exerts a protective role during the early phase of OGD in striatal neurons, although it does not shape the amplitude and the duration of the electrophysiological responses of these cells to EAA.
Anesthesiology/Critical Care Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland
This article has been cited by other articles:
![]() |
A. Tortiglione, B. Picconi, I. Barone, D. Centonze, S. Rossi, C. Costa, M. Di Filippo, A. Tozzi, M. Tantucci, G. Bernardi, et al. Na+/Ca2+ Exchanger Maintains Ionic Homeostasis in the Peri-Infarct Area Stroke, May 1, 2007; 38(5): 1614 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Annunziato, G. Pignataro, and G. F. Di Renzo Pharmacology of Brain Na+/Ca2+ Exchanger: From Molecular Biology to Therapeutic Perspectives Pharmacol. Rev., December 1, 2004; 56(4): 633 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, M. Cheng, and S. K. Chintala Kainic Acid-Mediated Upregulation of Matrix Metalloproteinase-9 Promotes Retinal Degeneration Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2374 - 2383. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Calabresi, E. Saulle, D. Centonze, A. Pisani, G. A. Marfia, and G. Bernardi Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability Brain, April 1, 2002; 125(4): 844 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Centonze, A. Pisani, P. Bonsi, P. Giacomini, G. Bernardi, and P. Calabresi Stimulation of Nitric Oxide-cGMP Pathway Excites Striatal Cholinergic Interneurons via Protein Kinase G Activation J. Neurosci., February 15, 2001; 21(4): 1393 - 1400. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |